5-YEAR SURVIVAL FOR STAGE-IC OR STAGE-1 GRADE-3 EPITHELIAL OVARIAN-CANCER TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引:32
作者
PIVER, MS [1 ]
MALFETANO, J [1 ]
BAKER, TR [1 ]
HEMPLING, RE [1 ]
机构
[1] ALBANY MED CTR,ALBANY,NY
关键词
D O I
10.1016/0090-8258(92)90232-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Thirty-two stage IC or stage I grade 3 patients with invasive ovarian adenocarcinoma were treated with 6 months of adjuvant cisplatin-based chemotherapy. With a median follow-up of 60.5 months, there have been three (9%) recurrences. The 5-year progression-free survival was 90.5% and the 5-year survival was 93.3%. © 1992.
引用
收藏
页码:357 / 360
页数:4
相关论文
共 8 条
[1]
TREATMENT OF OVARIAN CARCINOMA - POSSIBILITIES FOR PROGRESS [J].
BAGLEY, CM ;
CANELLOS, GP ;
YOUNG, RC ;
DEVITA, VT .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (17) :856-+
[2]
A PHASE-II TRIAL OF ADJUVANT CISPLATIN AND DOXORUBICIN IN STAGE-I EPITHELIAL OVARIAN-CANCER [J].
DOTTINO, PR ;
PLAXE, SC ;
COHEN, CJ .
GYNECOLOGIC ONCOLOGY, 1991, 43 (03) :203-205
[3]
FUKS Z, 1977, ISRAEL J MED SCI, V13, P815
[4]
NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[5]
STAGE-I OVARIAN EPITHELIAL CARCINOMA - SURVIVAL ANALYSIS FOLLOWING DEFINITIVE TREATMENT [J].
LENTZ, SS ;
CHA, SS ;
WIEAND, HS ;
PODRATZ, KC .
GYNECOLOGIC ONCOLOGY, 1991, 43 (03) :198-202
[6]
ADJUVANT CISPLATIN-BASED CHEMOTHERAPY FOR STAGE-1 OVARIAN ADENOCARCINOMA - A PRELIMINARY-REPORT [J].
PIVER, MS ;
MALFETANO, J ;
BAKER, TR ;
LELE, SB ;
MARCHETTI, DL .
GYNECOLOGIC ONCOLOGY, 1989, 35 (01) :69-72
[7]
ADJUVANT THERAPY IN STAGE-I AND STAGE-II EPITHELIAL OVARIAN-CANCER - RESULTS OF 2 PROSPECTIVE RANDOMIZED TRIALS [J].
YOUNG, RC ;
WALTON, LA ;
ELLENBERG, SS ;
HOMESLEY, HD ;
WILBANKS, GD ;
DECKER, DG ;
MILLER, A ;
PARK, R ;
MAJOR, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (15) :1021-1027
[8]
1979, WHO OFFSET PUBLICATI, V48